$2.13
At close: Nov 20, 5:11 PM EDT
$2.25
0.125.63%
After Hours: 5:11 PM EDT
Comments
Loading...
Alaunos Therapeutics (TCRT) Forecast
NewsEarningsAlaunos Therapeutics (TCRT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAlaunos Therapeutics (NASDAQ:TCRT) Stock Quotes, Forecast and News Summary
Alaunos Therapeutics Stock (NASDAQ: TCRT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Alaunos Therapeutics (TCRT) stock?
You can purchase shares of Alaunos Therapeutics (NASDAQ:TCRT) through any online brokerage.
Who are Alaunos Therapeutics (TCRT) competitors?
Other companies in Alaunos Therapeutics’s space includes: Tharimmune (NASDAQ:THAR), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI) and NuCana (NASDAQ:NCNA).
What is the forecast, or price target, for Alaunos Therapeutics (TCRT) stock?
Alaunos Therapeutics has a consensus price target of $3.00.
What is the current price for Alaunos Therapeutics (TCRT)?
The stock price for Alaunos Therapeutics (NASDAQ: TCRT) is $2.25 last updated November 20, 2024 at 5:11 PM EST.
Does Alaunos Therapeutics (TCRT) pay a dividend?
There are no upcoming dividends for Alaunos Therapeutics.
When is Alaunos Therapeutics (NASDAQ:TCRT) reporting earnings?
Alaunos Therapeutics’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Alaunos Therapeutics (TCRT) going to split?
There is no upcoming split for Alaunos Therapeutics.
What sector and industry does Alaunos Therapeutics (TCRT) operate in?
Alaunos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.